Cytori to Webcast Second Quarter Financial Results on August 4

SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will provide a live webcast of its second quarter financial results and business update on Thursday, August 4, 2016 at 5:30 PM Eastern Time.

The dial-in information is as follows:

Dial-In Number: +1.877.402.3914Conference ID: 54687177

Prior to the webcast at approximately 4:15 PM Eastern Time on August 4, Cytori will issue its second quarter earnings release which will review Cytori’s second quarter performance. The webcast will be available both live and by replay two hours after the call in the “Webcasts” section of the company’s investor relations website.

About Cytori Therapeutics, Inc.

Cytori Therapeutics is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. As a result, Cytori Cell Therapy™ may provide benefits across multiple disease states and can be made available to the physician and patient at the point-of-care through Cytori’s proprietary technologies and products. For more information: visit www.cytori.com or follow Cytori.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160722005088/en/

Cytori Therapeutics, Inc.
Tiago Girao, 1-858-458-0900
[email protected]

Source: Cytori Therapeutics, Inc.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c
• Arca Biopharma (ABIO) Reports Q1 Loss of $0.14